GlassScriptPhysician profile
Ryan J Jacobs
NPI 1548615750
$7,386.41
in general payments reported to CMS, 2019-2025
15 companies · $494 in 2025
The $494 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,368 · 2022: $789 · 2023: $2,408 · 2024: $2,328 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,229.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,226.55 | 2021-2025 | Octrode, Proclaim, Swift-Lock |
| Pfizer INC. | $226.49 | 2023-2024 | |
| Boston Scientific Corporation | $171.61 | 2021 | |
| Collegium Pharmaceutical, INC. | $131.63 | 2022-2024 | Belbuca |
| Davol INC. | $109.11 | 2023 | Progel Applicator Spray Tips |
| Abbvie INC. | $99.29 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $96.32 | 2023 | |
| Radius Health, INC. | $82.63 | 2022 | |
| Medtronic, INC. | $55.51 | 2023-2025 | Inceptiv, Synchromedii |
| Genentech USA, INC. | $46.18 | 2025 | Polivy |
| Amgen INC. | $37.03 | 2022 | |
| Foundation Fusion Solutions, LLC | $35.42 | 2023 | |
| Mallinckrodt Hospital Products INC. | $33.61 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.89 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.